|
METT10D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.156910E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.962030E-03 |
| Normal-vs-Stage2 |
4.596400E-01 |
| Normal-vs-Stage3 |
5.742600E-01 |
| Normal-vs-Stage4 |
7.574200E-01 |
| Stage1-vs-Stage2 |
4.400600E-01 |
| Stage1-vs-Stage3 |
2.824600E-01 |
| Stage1-vs-Stage4 |
1.971770E-01 |
| Stage2-vs-Stage3 |
8.792400E-01 |
| Stage2-vs-Stage4 |
4.759800E-01 |
| Stage3-vs-Stage4 |
5.831600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.360130E-03 |
| Normal-vs-AfricanAmerican |
5.574400E-02 |
| Normal-vs-Asian |
7.742600E-01 |
| Caucasian-vs-AfricanAmerican |
5.305000E-01 |
| Caucasian-vs-Asian |
3.171200E-01 |
| AfricanAmerican-vs-Asian |
3.169400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.313870E-02 |
| Normal-vs-Female |
2.063700E-03 |
| Male-vs-Female |
1.081610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.930200E-01 |
| Normal-vs-Extreme_Weight |
1.115380E-01 |
| Normal-vs-Obese |
3.623600E-03 |
| Normal-vs-Extreme_Obese |
2.868000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.975400E-01 |
| Normal_Weight-vs-Obese |
1.337170E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.852800E-01 |
| Extreme_Weight-vs-Obese |
2.948000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.964000E-01 |
| Obese-vs-Extreme_Obese |
8.937400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.355800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.196240E-04 |
| Normal-vs-Age(61-80Yrs) |
1.505160E-01 |
| Normal-vs-Age(81-100Yrs) |
5.527800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.503400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.664200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.110000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.207540E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.065700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.344800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.15860000005075E-06 |
| Normal-VS-Type2 PRCC |
3.427600E-01 |
| Normal-VS-KIRP CIMP |
2.195000E-01 |
| Normal-VS-Unclassified PRCC |
1.045960E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.57034999999084E-05 |
| Type1 PRCC-VS-KIRP CIMP |
9.027800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.085000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.509600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.968300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.723000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.205600E-01 |
| Normal-vs-N1 |
1.462220E-01 |
| Normal-vs-N2 |
6.800300E-02 |
| N0-vs-N1 |
1.284560E-01 |
| N0-vs-N2 |
8.552300E-02 |
| N1-vs-N2 |
5.998700E-03 |
|
|
